Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human gut metagenome

ABSTRACT: Intensive fresh fecal microbiota transplantation for refractory IgA nephropathy

PROVIDER: PRJNA630819 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11721663_1.fastq.gz	Fastqsanger.gz
	SRR11721663_2.fastq.gz	Fastqsanger.gz
	SRR11721664_1.fastq.gz	Fastqsanger.gz
	SRR11721664_2.fastq.gz	Fastqsanger.gz
	SRR11721665_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 42

Similar Datasets

human gut metagenome

Project description:Fecal microbiota transplantation for the gastrointestinal steroid-refractory graft-versus host disease using frozen capsule.

| PRJDB7070 | ENA

Impact of fecal microbiota transplantation (FMT) in 3 days-ABX-treated recipient mice using feces from 6 NSCLC patients at diagnosis.

Project description:This study aimed to analyze changes in gut microbiota composition in mice after transplantation of fecal microbiota (FMT, N = 6) from the feces of NSCLC patients by analyzing fecal content using 16S rRNA sequencing, 10 days after transplantation. Specific-pathogen-free (SPF) mice were used for each experiments (N=4) as controls.

2023-07-01 | E-MTAB-12812 | biostudies-arrayexpress

human gut metagenome

Project description:16S rRNA survey of fecal microbiota following fecal microbiota transplantation

| PRJNA238042 | ENA

human gut metagenome

Project description:Fecal microbiota transplantation treatment in refractory chronic GVHD patients after bone marrow transplantation: a pilot open-label, non-placebo-controlled study (PRJCA043679)

| PRJDB38997 | ENA

human gut metagenome

Project description:Fecal microbiota transplantation alleviates diabetes peripheral neuropathy

| PRJDB9649 | ENA

human gut metagenome

Project description:Fecal microbiota transplantation (FMT) for ulcerative colitis

| PRJNA285502 | ENA

human gut metagenome

Project description:Integrated Metagenomic and Metabolomic Profiling Reveals Gut Microbiota Dysbiosis and Metabolic Dysregulation in IgA Nephropathy and Membranous Nephropathy (PRJCA039250)

| PRJDB37437 | ENA

Expression data from human with IgA nephropathy (IgAN)

Project description:This SuperSeries is composed of the following subset Series: GSE35487: Expression data from human with IgA nephropathy (IgAN) [HG-U133A] GSE35488: Expression data from human with IgA nephropathy (IgAN) [HG-U133A_ENTREZG_10] Refer to individual Series

2012-02-02 | E-GEOD-35489 | biostudies-arrayexpress

Proteomics of The multinutrient Fortasyn Connect influences gut microbiota and intestinal function in early Alzheimer´s disease

Project description:Nutritional supplementation is emerging as a promising strategy to support the clinical management of early Alzheimer’s disease (AD), partly through modulation of the intestinal microbiome via the microbiota–gut–brain axis. This study investigated the impact of Fortasyn Connect (Souvenaid®), a multinutrient formulation, on the gut microbiota using a dual approach: i) a dynamic gastrointestinal simulator (simgi®) inoculated with fecal samples from AD patients, and ii) an observational study involving early-stage AD patients (n = 22) receiving or not the supplement. The in vitro model provided a host-independent assessment of microbiota responses, revealing increased Bifidobacterium and Lactobacillus levels, along with enhanced short-chain fatty acid (SCFA) production. In patients, supplementation was associated with higher fecal abundance of Bifidobacterium and Christensenellaceae, reduced inflammatory markers (calprotectin and myeloperoxidase), and elevated butyrate levels. Fecal lipidomic and proteomic analyses indicated improved lipid digestion, increased secretory IgA, and modulation of host proteins related to gut–brain homeostasis. Systemically, higher circulating levels of iron, folate, and vitamin B12 were also observed. This study demonstrates that multinutrient supplementation such as Fortasyn Connect can beneficially modulate the gut ecosystem and immune–metabolic pathways in early AD, targeting disease-relevant mechanisms through the gut–brain axis in the context of aging.

2025-12-03 | PXD069669 | Pride

human gut metagenome

Project description:Microbiome sequencing of ulcerative colitis patients receiving fecal microbiota transplantation

| PRJNA737472 | ENA